Clinical Research Directory
Browse clinical research sites, groups, and studies.
Liver Fibrosis Assessment in Diabetic Patients
Sponsor: National Taiwan University Hospital
Summary
The investigators plan to use the smartphone App for FIB-4 calculation and increase the awareness of liver fibrosis. These patients might notify and discuss with the physician of their liver fibrosis severity to improve the identification, and management of liver fibrosis. This is to establish a patient-centered clinical pathway to identify patients with advanced fibrosis in type 2 diabetes patients. The investigators plan to conduct this randomized controlled trial of two groups: FIB-4 APP group and the standard care group. The primary end point is the referral rate of patients with advanced fibrosis (FIB-4 ≥ 2.67).
Official title: A Randomized Controlled Trial for Liver Fibrosis Assessment in Diabetic Patients
Key Details
Gender
All
Age Range
35 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
540
Start Date
2024-11-22
Completion Date
2025-12-31
Last Updated
2024-11-22
Healthy Volunteers
No
Interventions
APP calculation for FIB-4
the investigators plan to use the smartphone App for FIB-4 calculation and notify the patients.
Standard Care (in control arm)
The standard group proceeds as regular practice
Locations (1)
National Taiwan University Hospital
Taipei, Taiwan